Our results show that VEGF concentrations as well as HE4 and CA125 levels in all groups of ovarian cancer patients were statistically significantly higher in comparison to the group of healthy subjects and patients with benign tumors (exception CA125 I stage). The gene discussed is VEGFA; the disease is ovarian carcinoma.